Michael L. Chen

Michael L. Chen

Auto-generated profile, based on publicly available information

Michael L. Chen

Department of Dermatology, School of Medicine, Stanford University , Stanford, CA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
JKJiyeong Kim
Jiyeong Kim
ZCZhuo Ran Cai
Zhuo Ran Cai
MCMichael L Chen
Michael L Chen
SOSonia Onyeka
Sonia Onyeka
JKJustin M Ko
Justin M Ko
ELEleni Linos
Eleni Linos
Background: The COVID-19 pandemic rapidly changed the landscape of clinical practice in the United States; telehealth became an essential mode of health care delivery, yet many components of telehealth use remain unknown years after the disease’s emergence. Objective: We aim to comprehensively assess telehealth use and its associated factors in the United States. Methods: This cross-sectional study used a nationally representative survey (Health Information National Trends Survey) administered to US adults (≥18 years) from March 2022 through November 2022. To assess telehealth adoption, perceptions of telehealth, satisfaction with telehealth, and the telehealth care purpose, we conducted weighted descriptive analyses. To identify the subpopulations with low adoption of telehealth, we developed a weighted multivariable logistic regression model. Results: Among a total of 6252 survey participants, 39.3% (2517/6252) reported telehealth use in the past 12 months (video: 1110/6252, 17.8%; audio: 876/6252, 11.6%). The most prominent reason for not using telehealth was due to telehealth providers failing to offer this option (2200/3529, 63%). The most common reason for respondents not using offered telehealth services was a preference for in-person care (527/578, 84.4%). Primary motivations to use telehealth were providers’ recommendations (1716/2517, 72.7%) and convenience (1516/2517, 65.6%), mainly for acute minor illness (600/2397, 29.7%) and chronic condition management (583/2397, 21.4%), yet care purposes differed by age, race/ethnicity, and income. The satisfaction rate was predominately high, with no technical problems (1829/2517, 80.5%), comparable care quality to that of in-person care (1779/2517, 75%), and no privacy concerns (1958/2517, 83.7%). Younger individuals (odd ratios [ORs] 1.48-2.23; 18-64 years vs ≥75 years), women (OR 1.33, 95% CI 1.09-1.61), Hispanic individuals (OR 1.37, 95% CI 1.05-1.80; vs non-Hispanic White), those with more education (OR 1.72, 95% CI 1.03-2.87; at least a college graduate vs less than high school), unemployed individuals (OR 1.25, 95% CI 1.02-1.54), insured individuals (OR 1.83, 95% CI 1.25-2.69), or those with poor general health status (OR 1.66, 95% CI 1.30-2.13) had higher odds of using telehealth. Conclusions: To our best knowledge, this is among the first studies to examine patient factors around telehealth use, including motivations to use, perceptions of, satisfaction with, and care purpose of telehealth, as well as sociodemographic factors associated with telehealth adoption using a nationally representative survey. The wide array of descriptive findings and identified associations will help providers and health systems understand the factors that drive patients toward or away from telehealth visits as the technology becomes more routinely available across the United States, providing future directions for telehealth use and telehealth research.

2 February 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ZCZhuo Ran Cai
Zhuo Ran Cai
MCMichael L. Chen
Michael L. Chen
JKJiyeong Kim
Jiyeong Kim
RNRoberto A. Novoa
Roberto A. Novoa
LBLeandra A. Barnes
Leandra A. Barnes
ELEleni Linos
Eleni Linos

26 June 2025 in British Journal of Dermatology
Verified
Journal Article
Open access
ZCZhuo Ran Cai
Zhuo Ran Cai
JKJiyeong Kim
Jiyeong Kim
SRShawheen J Rezaei
Shawheen J Rezaei
MCMichael L Chen
Michael L Chen
FTFadi Touma
Fadi Touma
ELEleni Linos
Eleni Linos
Background: Artificial intelligence (AI) applications in dermatology have expanded beyond diagnosis and have shifted towards assessing disease severity. Objectives: To qualitatively and quantitatively evaluate the performance of image-based AI models in severity assessment for various skin diseases. Methods: In this systematic review and meta-analysis, we collected studies using four electronic databases, including PubMed, Embase, Institute of Electrical and Electronics Engineers Xplore and Web of Science, published from 1 January 2017 to 6 April 2023, and updated the search in November 2023. Studies assessing the performance of deep learning AI models on the severity of skin diseases were included. We excluded studies that utilized a nonvalidated severity index, lacked clinical images, and assessed wounds, ulcers or burns. Two independent reviewers extracted prespecified study characteristics for the summary table. For the meta-analysis, contingency tables were extracted, when possible, and reconstructed for each severity measure. Accuracy was calculated using a bivariate model in Metandi package, and meta-regression was performed by disease type and scoring system. This study was registered with PROSPERO (CRD42023487228). Results: Our initial search identified 7737 records. After duplicate removal and abstract screening, we reviewed the full text of 192 articles and included 45 studies for systematic review and 19 for meta-analysis. The pooled sensitivity and specificity of AI models were 80.5% [95% confidence interval (CI) 76.2–84.2] and 96.2% (95% CI 94.9–97.2), respectively. Moreover, pooled sensitivity differed by disease (atopic dermatitis 91.8% vs. acne 80.7%, P = 0.005; acne 80.4% vs. psoriasis 71.1%, P = 0.044) and scoring system [Eczema Area and Severity Index 97.3% vs. Investigator’s Global Assessment (IGA) for atopic dermatitis 78.9%, P < 0.001; Hayashi Grading 89.7% vs. IGA for acne 69.8%, P < 0.001]. Conclusions: Our findings show that current AI models exhibit a high level of capacity in disease severity assessment. Nevertheless, efforts are urgently needed to improve transparency in data reporting and conduct high-quality prospective studies using objective reference standards in clinical settings to generate reliable evidence.

23 October 2022 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
MCMichael L Chen
Michael L Chen
VRVeronica Rotemberg
Veronica Rotemberg
JLJenna C Lester
Jenna C Lester
RNRoberto A Novoa
Roberto A Novoa
ACAlbert S Chiou
Albert S Chiou
RDRoxana Daneshjou
Roxana Daneshjou
Dear Editor, Artificial intelligence (AI) algorithms are increasingly used for clinical tasks within dermatology, with some algorithms having regulatory approval in Europe and Australia.1 However, there are concerns about the transparency of these algorithms regarding patient diversity.1,2 Recent work showed that Fitzpatrick skin tone information was reported in only 10% of dermatological AI datasets.1 To our knowledge, differences in dermatology AI performance based on sex and gender have not been investigated. A randomized, prospective clinical trial found that an AI algorithm performed poorly on diagnoses it had never encountered during algorithmic training.3 To understand whether certain diagnoses are not represented among dermatology AI algorithms, we conducted a scoping review of published algorithms and assessed potential biases against women or patients with skin of colour.

8 July 2024 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
MCMichael L Chen
Michael L Chen
JKJiyeong Kim
Jiyeong Kim
HNHaley B Naik
Haley B Naik
MAMaria A Aleshin
Maria A Aleshin
KSKavita Y Sarin
Kavita Y Sarin
ELEleni Linos
Eleni Linos
Dear Editor, Hidradenitis suppurativa (HS) is a chronic skin condition that touches many aspects of patients’ quality of life.1–3 Secure patient messaging is a common mode of patient–physician communication that may improve access to care.4 Our study sought to identify common topics of patient messages and factors associated with these topics in a large cohort of patients with HS.

26 July 2023 in JMIR Preprints
Verified
Preprint
Open access
JKJiyeong Kim
Jiyeong Kim
ZCZhuo Ran Cai
Zhuo Ran Cai
MCMichael L Chen
Michael L Chen
SOSonia Onyeka
Sonia Onyeka
JKJustin M Ko
Justin M Ko
ELEleni Linos
Eleni Linos
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The COVID-19 pandemic rapidly changed the landscape of clinical practice in the United States; telehealth became an essential mode of health care delivery, yet many components of telehealth use remain unknown years after the disease’s emergence. Objective: We aim to comprehensively assess telehealth use and its associated factors in the United States. Methods: This cross-sectional study used a nationally representative survey (Health Information National Trends Survey) administered to US adults (≥18 years) from March 2022 through November 2022. To assess telehealth adoption, perceptions of telehealth, satisfaction with telehealth, and the telehealth care purpose, we conducted weighted descriptive analyses. To identify the subpopulations with low adoption of telehealth, we developed a weighted multivariable logistic regression model. Results: Among a total of 6252 survey participants, 39.3% (2517/6252) reported telehealth use in the past 12 months (video: 1110/6252, 17.8%; audio: 876/6252, 11.6%). The most prominent reason for not using telehealth was due to telehealth providers failing to offer this option (2200/3529, 63%). The most common reason for respondents not using offered telehealth services was a preference for in-person care (527/578, 84.4%). Primary motivations to use telehealth were providers’ recommendations (1716/2517, 72.7%) and convenience (1516/2517, 65.6%), mainly for acute minor illness (600/2397, 29.7%) and chronic condition management (583/2397, 21.4%), yet care purposes differed by age, race/ethnicity, and income. The satisfaction rate was predominately high, with no technical problems (1829/2517, 80.5%), comparable care quality to that of in-person care (1779/2517, 75%), and no privacy concerns (1958/2517, 83.7%). Younger individuals (odd ratios [ORs] 1.48-2.23; 18-64 years vs ≥75 years), women (OR 1.33, 95% CI 1.09-1.61), Hispanic individuals (OR 1.37, 95% CI 1.05-1.80; vs non-Hispanic White), those with more education (OR 1.72, 95% CI 1.03-2.87; at least a college graduate vs less than high school), unemployed individuals (OR 1.25, 95% CI 1.02-1.54), insured individuals (OR 1.83, 95% CI 1.25-2.69), or those with poor general health status (OR 1.66, 95% CI 1.30-2.13) had higher odds of using telehealth. Conclusions: To our best knowledge, this is among the first studies to examine patient factors around telehealth use, including motivations to use, perceptions of, satisfaction with, and care purpose of telehealth, as well as sociodemographic factors associated with telehealth adoption using a nationally representative survey. The wide array of descriptive findings and identified associations will help providers and health systems understand the factors that drive patients toward or away from telehealth visits as the technology becomes more routinely available across the United States, providing future directions for telehealth use and telehealth research.